Nurix Therapeutics, Inc. NRIX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s common stock, shares issued (in shares)?
- Nurix Therapeutics, Inc. (NRIX) reported common stock, shares issued (in shares) of $103.4M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Nurix Therapeutics, Inc.'s common stock, shares issued (in shares) increased by 35.6% year-over-year, from $76.23M to $103.4M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s common stock, shares issued (in shares)?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s common stock, shares issued (in shares) has grown at a 29.2% compound annual growth rate (CAGR), from $47.17M to $101.81M.